InvestorsHub Logo
Followers 145
Posts 27567
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Thursday, 11/05/2020 7:39:23 AM

Thursday, November 05, 2020 7:39:23 AM

Post# of 3988
Protalix BioTherapeutics to Present at the H.C. Wainwright 6th Annual Israel Conference

Thu, November 5, 2020, 1:50 PM GMT+2
CARMIEL, Israel, Nov. 5, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced that Dror Bashan, the Company's President and Chief Executive Officer will present at the H.C. Wainwright 6th Annual Israel Conference on Thursday, November 12, 2020 at 7:30 AM, Eastern Standard Time. The conference will be held virtually on November 12, 2020.

A live webcast of the presentation will be available at www.protalix.com on the event calendar page, https://protalixbiotherapeutics.gcs-web.com/events0?c=101161&p=irol-calendar. A replay of the presentation will be archived and available for at least 15 days following the presentation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News